Extranodal NK-T-cell lymphoma epidemiology and demographics
|
Extranodal NK-T-cell lymphoma Microchapters |
|
Differentiating Extranodal NK-T-cell lymphoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Extranodal NK-T-cell lymphoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Extranodal NK-T-cell lymphoma epidemiology and demographics |
|
FDA on Extranodal NK-T-cell lymphoma epidemiology and demographics |
|
CDC on Extranodal NK-T-cell lymphoma epidemiology and demographics |
|
Extranodal NK-T-cell lymphoma epidemiology and demographics in the news |
|
Blogs on Extranodal NK-T-cell lymphoma epidemiology and demographics |
|
Risk calculators and risk factors for Extranodal NK-T-cell lymphoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ramyar Ghandriz MD[2] Sowminya Arikapudi, M.B,B.S. [3]
Overview
Epidemiology and Demographics
Incidence
- Natural Killer (NK) cell lymphoma is a rare disease. NK/T cell lymphoma, nasal type (NKTCL) and aggressive NK-cell leukemia (ANKCL) have a higher incidence in Asia, Central, and South America.
- Nk cell lymphoma is usually associated with Epstein-Barr virus infection.
- NK T cell lymphoma, nasal type consist 3-10% of non-Hodgkin lymphoma in Asia and South America and less than 1% in Western countries.[1]
Mortality rate
- NK cell lymphoma shows a poor prognosis because of rapid local progression and distant metastasis.
References
- ↑ Liu J, Song B, Fan T, Huang C, Xie C, Li J; et al. (2011). "Pathological and clinical characteristics of 1,248 non-Hodgkin's lymphomas from a regional cancer hospital in Shandong, China". Asian Pac J Cancer Prev. 12 (11): 3055–61. PMID 22393989.